Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francesca Dominici, Ph.D.

Co-Author

This page shows the publications co-authored by Francesca Dominici and Joel Schwartz.
Connection Strength

2.650
  1. A self-controlled approach to survival analysis, with application to air pollution and mortality. Environ Int. 2021 Dec; 157:106861.
    View in: PubMed
    Score: 0.248
  2. A Direct Estimate of the Impact of PM2.5, NO2, and O3 Exposure on Life Expectancy Using Propensity Scores. Epidemiology. 2021 07 01; 32(4):469-476.
    View in: PubMed
    Score: 0.245
  3. Long-Term Association of Air Pollution and Hospital Admissions Among Medicare Participants Using a Doubly Robust Additive Model. Circulation. 2021 Apr 20; 143(16):1584-1596.
    View in: PubMed
    Score: 0.239
  4. Causal Effects of Air Pollution on Mortality Rate in Massachusetts. Am J Epidemiol. 2020 11 02; 189(11):1316-1323.
    View in: PubMed
    Score: 0.234
  5. Short term exposure to fine particulate matter and hospital admission risks and costs in the Medicare population: time stratified, case crossover study. BMJ. 2019 11 27; 367:l6258.
    View in: PubMed
    Score: 0.220
  6. Estimating the Effects of PM2.5 on Life Expectancy Using Causal Modeling Methods. Environ Health Perspect. 2018 12; 126(12):127002.
    View in: PubMed
    Score: 0.205
  7. Association of Short-term Exposure to Air Pollution With Mortality in Older Adults. JAMA. 2017 12 26; 318(24):2446-2456.
    View in: PubMed
    Score: 0.192
  8. Air Pollution and Mortality in the Medicare Population. N Engl J Med. 2017 10 12; 377(15):1498-9.
    View in: PubMed
    Score: 0.190
  9. Air Pollution and Mortality in the Medicare Population. N Engl J Med. 2017 06 29; 376(26):2513-2522.
    View in: PubMed
    Score: 0.186
  10. Heat stroke admissions during heat waves in 1,916 US counties for the period from 1999 to 2010 and their effect modifiers. Environ Health. 2016 08 08; 15(1):83.
    View in: PubMed
    Score: 0.175
  11. A national case-crossover analysis of the short-term effect of PM2.5 on hospitalizations and mortality in subjects with diabetes and neurological disorders. Environ Health. 2014 May 22; 13(1):38.
    View in: PubMed
    Score: 0.150
  12. Hierarchical bivariate time series models: a combined analysis of the effects of particulate matter on morbidity and mortality. Biostatistics. 2004 Jul; 5(3):341-60.
    View in: PubMed
    Score: 0.075
  13. PM2.5 and hospital admissions among Medicare enrollees with chronic debilitating brain disorders. Sci Total Environ. 2021 Feb 10; 755(Pt 2):142524.
    View in: PubMed
    Score: 0.058
  14. County-level radon exposure and all-cause mortality risk among Medicare beneficiaries. Environ Int. 2019 09; 130:104865.
    View in: PubMed
    Score: 0.053
  15. Long-term PM2.5 Exposure and Neurological Hospital Admissions in the Northeastern United States. Environ Health Perspect. 2016 01; 124(1):23-9.
    View in: PubMed
    Score: 0.040
  16. PM2.5 and survival among older adults: effect modification by particulate composition. Epidemiology. 2015 May; 26(3):321-7.
    View in: PubMed
    Score: 0.040
  17. The impact of source contribution uncertainty on the effects of source-specific PM2.5 on hospital admissions: a case study in Boston, MA. J Expo Sci Environ Epidemiol. 2014 Jul; 24(4):365-71.
    View in: PubMed
    Score: 0.037
  18. The effect of primary organic particles on emergency hospital admissions among the elderly in 3 US cities. Environ Health. 2013 Aug 27; 12(1):68.
    View in: PubMed
    Score: 0.036
  19. Air pollution and health: a European and North American approach (APHENA). Res Rep Health Eff Inst. 2009 Oct; (142):5-90.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.